Cytek Biosciences (CTKB) has introduced an Enhanced Small Particle, or ESP, Detection Option for its Cytek Aurora CS system. This is the first commercially available small particle detector on a cell sorter and offers a significant advancement for rapidly evolving research fields, including in drug delivery, cell therapy, disease diagnostics, circulating tumor cells, regenerative medicine, and vaccine delivery. Researchers can now achieve downstream analysis of materials that were previously unable to be sorted, opening new possibilities for breakthroughs in these areas.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTKB:
- Trump Media, broader market surge after Trump wins election: Morning Buzz
- Cytek Biosciences’ Q3 2024 Financial Highlights
- Cytek Biosciences reports Q3 EPS 1c, consensus (2c)
- CTKB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cytek Biosciences announces resignation of Chief Operating Officer